These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 21145597)
21. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Hammer LA; Waldner H; Zagon IS; McLaughlin PJ Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376 [TBL] [Abstract][Full Text] [Related]
22. The role of antibodies in multiple sclerosis. Weber MS; Hemmer B; Cepok S Biochim Biophys Acta; 2011 Feb; 1812(2):239-45. PubMed ID: 20600871 [TBL] [Abstract][Full Text] [Related]
24. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats. Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642 [TBL] [Abstract][Full Text] [Related]
25. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis. Korn T; Mitsdoerffer M; Kuchroo VK Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635 [TBL] [Abstract][Full Text] [Related]
26. The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Braitch M; Constantinescu CS Inflamm Allergy Drug Targets; 2010 Sep; 9(4):249-56. PubMed ID: 20887272 [TBL] [Abstract][Full Text] [Related]
27. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130 [TBL] [Abstract][Full Text] [Related]
28. Regulatory B cells in experimental autoimmune encephalomyelitis (EAE). Ray A; Basu S Methods Mol Biol; 2014; 1190():243-55. PubMed ID: 25015285 [TBL] [Abstract][Full Text] [Related]
30. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303 [TBL] [Abstract][Full Text] [Related]
31. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis. Sefia E; Pryce G; Meier UC; Giovannoni G; Baker D Mult Scler Relat Disord; 2017 May; 14():46-50. PubMed ID: 28619431 [TBL] [Abstract][Full Text] [Related]
32. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Van Kaer L; Postoak JL; Wang C; Yang G; Wu L Cell Mol Immunol; 2019 Jun; 16(6):531-539. PubMed ID: 30874627 [TBL] [Abstract][Full Text] [Related]
33. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634 [TBL] [Abstract][Full Text] [Related]
34. The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model. Anwar Jagessar S; Fagrouch Z; Heijmans N; Bauer J; Laman JD; Oh L; Migone T; Verschoor EJ; 't Hart BA J Neuroimmune Pharmacol; 2013 Jun; 8(3):727-38. PubMed ID: 23508625 [TBL] [Abstract][Full Text] [Related]
35. IFN-β differentially regulates the function of T cell subsets in MS and EAE. Kavrochorianou N; Markogiannaki M; Haralambous S Cytokine Growth Factor Rev; 2016 Aug; 30():47-54. PubMed ID: 27033173 [TBL] [Abstract][Full Text] [Related]
36. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. Tacke S; Chunder R; Schropp V; Urich E; Kuerten S Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328594 [TBL] [Abstract][Full Text] [Related]
37. Ozanimod-mediated remission in experimental autoimmune encephalomyelitis is associated with enhanced activity of CNS CD27 Kamyan D; Hassane M; Alnaqbi A; Souid AK; Rasbi ZA; Tahrawi AA; Shamsi MA Front Immunol; 2024; 15():1230735. PubMed ID: 38533505 [TBL] [Abstract][Full Text] [Related]
38. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745 [TBL] [Abstract][Full Text] [Related]
39. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis. Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035 [TBL] [Abstract][Full Text] [Related]
40. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]